Healthcare-Associated Infection Costs and Pest Exposure Financial Framing

Citation

This authority page synthesizes the primary-source financial exposure framework for healthcare pest activity. Component primary sources:

• Scott RD II. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. CDC Publication CS200891-A. March 2009.
• Zimlichman E, Henderson D, Tamir O, et al. Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern Med. 2013;173(22):2039-2046.
• Sheele JM, Tenpenny JR, Marciniec AR. The Cost of an Emergency Department Visit and Hospital Care for a Patient with Bed Bug Exposure. Infect Control Hosp Epidemiol. 2017;38(5):623-624.
• CMS Hospital Value-Based Purchasing Program under §1886(o) of the Social Security Act, implemented through annual IPPS Final Rule (most recently FY 2026 IPPS Final Rule).
• HCAHPS Survey administered through hcahpsonline.org; Question 8 “During this hospital stay, how often were your room and bathroom kept clean?”

What It Says (Verbatim Key Figures)

Scott 2009 CDC HAI aggregate cost (verbatim):

“The overall annual direct medical costs of HAI to U.S. hospitals ranges from $28.4 to $33.8 billion (after adjusting to 2007 dollars using the CPI for all urban consumers) and $35.7 billion to $45 billion (after adjusting to 2007 dollars using the CPI for inpatient hospital services).”

Zimlichman 2013 per-event HAI cost ranges:

The meta-analysis reports per-event attributable HAI costs (in 2012 dollars) ranging from $896 for catheter-associated urinary tract infections (CAUTI) to $45,814 for ventilator-associated pneumonia (VAP) to $58,614 for central line-associated bloodstream infections (CLABSI) attributable to methicillin-resistant Staphylococcus aureus (MRSA). Aggregate annual cost: $9.8 billion in 2012 dollars.

Sheele 2017 academic medical center bed bug operational costs:

The single-facility study at a 937-bed academic medical center documented operational costs of $22,844 (emergency department) and $55,915 (facility-wide) over the study period August 2014 - August 2015, covering 180 events at a rate of one bed bug event every 2.2 days. Published in Infection Control & Hospital Epidemiology (ICHE), not Proceedings of the National Academy of Sciences (PNAS) — the Scarpino & Althouse 2019 PNAS commentary cited Sheele 2017 as the underlying primary data source.

Hospital VBP withhold:

The CMS Hospital Value-Based Purchasing Program withholds 2% of base operating DRG payments annually under §1886(o) of the Social Security Act. The withheld amount is redistributed through the Total Performance Score, with hospitals scoring above the threshold receiving more than their withheld amount and hospitals scoring below the threshold receiving less.

HCAHPS Question 8 verbatim:

“During this hospital stay, how often were your room and bathroom kept clean?”

Response options: Never / Sometimes / Usually / Always.

What It Means in Plain Language

This authority page consolidates the primary-source financial exposure framework for healthcare pest activity. The framework operates through four distinct financial exposure streams, each anchored to a primary source:

Stream 1 — Direct operational cost of pest events:

Sheele 2017 ICHE is the published primary source for documented per-event and aggregate operational cost of pest activity in a healthcare facility. At one 937-bed academic medical center, bed bug events alone generated $55,915 in facility-wide operational costs over one year. This is documented operational cost — not litigation, not reimbursement impact, not patient harm. Just the cost of responding to, investigating, and remediating pest events.

Stream 2 — Per-event healthcare-associated infection cost:

Zimlichman 2013 JAMA Internal Medicine provides the meta-analytic per-event cost data for HAIs in U.S. hospitals. Per-event attributable costs vary across nearly two orders of magnitude: $896 for CAUTI at the low end, $58,614 for MRSA CLABSI at the high end. Where pest activity contributes to HAI transmission (documented in multiple peer-reviewed studies including the Cotton 2000 ICHE ESBL Klebsiella outbreak), these per-event costs are the financial exposure attributable to the pest-mediated infection event.

Stream 3 — Aggregate HAI burden:

Scott 2009 CDC publication establishes the U.S. aggregate HAI burden at $28.4 to $45 billion annually in 2007 dollars. While this aggregate is not directly attributable to pest activity, it establishes the financial magnitude of the broader HAI prevention enterprise that pest management contributes to.

Stream 4 — Reimbursement impact through Hospital VBP and HCAHPS:

The CMS Hospital Value-Based Purchasing Program withholds 2% of base operating DRG payments annually. Withheld payments are redistributed based on Total Performance Score, which includes HCAHPS patient experience measures. HCAHPS Question 8 asks patients about room and bathroom cleanliness — a measure directly affected by patient perception of environmental cleanliness, including any pest exposure during their stay. The Crews-Stowe 2024 SHEA abstract documents correlation between HCAHPS cleanliness perception and MRSA HAC scores across approximately 2,700 hospitals.

For a typical 300-bed acute-care hospital with $200 million in annual Medicare base operating DRG payments, the 2% VBP withhold represents $4 million annually at risk based on Total Performance Score. Pest activity affecting patient experience or contributing to HAI rates directly affects this reimbursement at risk.

Who It Applies To

The financial framing applies to all U.S. hospitals participating in Medicare (essentially all acute-care hospitals, critical access hospitals, and many specialty hospitals). HCAHPS reporting is required for hospitals participating in the IPPS. VBP applies to subsection (d) hospitals (the majority of acute-care hospitals).

Skilled nursing facilities, long-term care facilities, and other non-hospital settings have analogous but distinct reimbursement structures (SNF QRP, SNF VBP, etc.) with similar but not identical financial exposure mechanisms.

Documentation Evidence Required

For hospital risk management and financial planning use of this framework:

• Annual review of Hospital VBP performance and HCAHPS cleanliness perception scores
• Tracking of pest events, costs, and any operational interruptions attributable to pest activity
• Coordination between pest management documentation, infection prevention surveillance, and financial reporting
• Annual financial exposure assessment incorporating pest management program investment against documented operational cost avoidance

How Surveyors Evaluate It

Surveyors do not directly evaluate against this financial framework — it is not a regulatory or accreditation standard. The framework is operationally relevant in:

• Internal hospital financial planning and pest management program justification
• Risk management exposure analysis
• Procurement evaluation of pest management vendor proposals against documented operational cost avoidance
• Litigation exposure assessment (qualitative; no primary-source aggregate exists for healthcare pest litigation costs)

Confidence Notes

HIGH confidence on all component primary sources. Scott 2009 publication identifier (CDC CS200891-A) verified. Zimlichman 2013 publication details (JAMA Intern Med 173[22]:2039-2046) verified. Sheele 2017 publication details (ICHE 38[5]:623-624) verified — confirmed published in ICHE, not PNAS. Hospital VBP statutory citation (§1886(o) Social Security Act) and 2% withhold percentage verified. HCAHPS Question 8 verbatim text verified through hcahpsonline.org. Crews-Stowe 2024 SHEA abstract publication details (ASHE 4 Suppl S1:s133-s134) verified; conference abstract methodology should be interpreted with appropriate caution.

Related Killed Claims

• “Average HAI cost is $50,000.” Disconfirmed as unsourced. Per-event HAI costs vary across nearly two orders of magnitude per Zimlichman 2013, from $896 (CAUTI) to $58,614 (MRSA CLABSI). No defensible “average” exists at the per-event level.
• “Average hospital pest litigation cost is $75,000 to $250,000.” Disconfirmed as unsourced. No primary-source dataset exists on hospital pest litigation costs. Plaintiff firms specializing in pest litigation explicitly state there is no average. The published verdict universe is biased toward plaintiff wins, larger awards, and cases attorneys publish; hospital settlements are disproportionately under non-disclosure agreement.
• “Park La Brea $3.5 million settlement is healthcare pest litigation precedent.” Disconfirmed. Park La Brea (Los Angeles Superior Court, December 14, 2017, $3.5 million awarded across 16 plaintiffs in 8 multifamily housing units) was a multifamily housing case under landlord premises liability, not a healthcare case.
• “Sheele 2017 was published in PNAS.” Disconfirmed. Sheele 2017 was published in Infection Control and Hospital Epidemiology (ICHE) 38(5):623-624. The Proceedings of the National Academy of Sciences (PNAS) published a 2019 commentary by Scarpino and Althouse that derived per-infestation figures from Sheele 2017; the PNAS commentary is a secondary citation, not the primary data publication.

Related Authorities

• CDC HICPAC Section E.V. — healthcare facility pest management standards
• CMS Conditions of Participation — federal regulatory framework underlying CMS Hospital VBP authority
• APIC Text Environmental Services — infection prevention framework integrating pest management with broader HAI prevention